Submit manuscript...
Journal of
eISSN: 2376-0060

Lung, Pulmonary & Respiratory Research

Editorial Volume 8 Issue 3

Post-Acute-COVID-19-illness renal sequelae

Attapon Cheepsattayakorn, Ruangrong Cheepsattayakorn, Porntep Siriwanarangsun

Correspondence: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Changklan Muang Chiang Mai 50100, Thailand

Received: June 12, 2021 | Published: July 23, 2021

Citation: Cheepsattayakorn A, Cheepsattayakorn R, Siriwanarangsun P. Post-Acute-COVID-19-illness renal sequelae. J Lung Pulm Respir Res. 2021;8(3):94. DOI: 10.15406/jlprr.2021.08.00258

Download PDF

Renal biopsies and autopsies in COVID-19-associated nephropathy (COVAN) patients revealed characteristically collapsing variant of focal segmental glomerulosclerosis, accompanying involution of the glomerular tuft and acute tubular injury in response to the activation of the chemokine and interferon,1-4 in addition to renal microcirculation thrombi.5 In acute-kidney-injury-susceptible COVID-19 patients, SARS-CoV-2  acts as a second hit that is similar to HIV and other virus.3 In hospitalized-COVID-19 patients and mechanical-ventilation-required-critically-ill-COVID-19 patients, severe acute kidney injury (AKI) requiring renal replacement therapy (RRT) occurs in approximately 5 % and 20 %-31 %, respectively.6-9 Short-term follow-up in several previous early studies in RRT-required patients demonstrated that around 27 %-64 % of them were dialysis independent by 28 days or ICU discharge.8,10 At 6 months after acute-COVID-19 phase in the post-acute-COVID-19 Chinese study, around 35 % of patients revealed reduction of the estimated glomerular filtration rate (eGFR; < 90 ml/min per 1.73 m2) and 13 % of them developed new-onset decrease of eGFR after revealed normal eGFR during acute COVID-19 phase.11 Approximately, 84 % of the COVID-19 survivors demonstrated renal recovery and a survival probability of 0.46 at 60 day following the acute COVID-19 phase.9 AKI survivor clinics will provide the benefits to COVID-19 survivors with persistent impaired renal function.12,13 

In conclusion, COVID-19 survivors with persistent impaired renal function should be early and close followed up in post-acute-COVID-19 AKI clinics.

References

  1. Golmai P. Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19. J Am Soc Nephrol. 2020;31(9):1944‒1947.
  2. Santoriello D. Postmortem kidney pathology findings in patients with COVID-19. J Am Soc Nephrol. 2020;31(9):2158‒2167.
  3. Velez JCQ, Caza T, Larsen CP. COVAN is the new HIVAN : the re-emergence of collapsing glomerulopathy with COVID-19. Nat Rev Nephrol. 2020;16(10):565‒567.
  4. Peleg Y. Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep. 2020;5(6):940‒945.
  5. Jhaveri KD. Thrombotic microangiopathy in a patient with COVID-19. Kidney Int. 2020;98(2):509‒512.
  6. Robbin-Juarez SY. Outcomes for patients with COVID-19 and acute kidney injury : a systematic review and meta-analysis. Kidney Int Rep. 2020;5(8):1149‒1160.
  7. Commings MJ. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City : a prospective cohort study. Lancet. 2020;395(10239):1763‒1770.
  8. Gupta S. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1‒12.
  9. Steven JS. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PLoS ONE. 2020;15(12):e0244131.
  10. Wilbers TJ, Koning MV. Renal replacement therapy in critically ill patients with COVID-19: a retrospective study investigating mortality, renal recovery and filter lifetime. J Crit Care. 2020;60:103‒105.
  11. Huang C. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220‒232.
  12. Harel Z. Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int. 2013;83:901‒908.
  13. Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID-19 : causality or coincidence? : a report of three cases. J Med Virol. 2021;93(2):1150‒1153.
Creative Commons Attribution License

©2021 Cheepsattayakorn, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.

Citations